Related Experiment Video
Updated: May 13, 2026

Intralymphatic Immunotherapy and Vaccination in Mice
Published on: February 2, 2014
Is self-administration of subcutaneous immunoglobulin therapy safe in a home care setting?
Lynn Lednik1, Mary Baker, Karen Sullivan
1Home Health Agency, Division of Home Health Services, Cincinnati Children's Hospital, Cincinnati, OH, USA. lynn.lednik@cchmc.org
Abstract:
Clinical practice based on best evidence can help ensure that patients receive safe and appropriate care from nurses. Members of a nursing inquiry council at a pediatric-based organization addressed the issue of patient-administered immunoglobulin therapy in the home care setting through conducting an evidence-based practice (EBP) project. Following the steps of EBP, an EBP change was implemented that allowed families the option of immunoglobulin therapy administration by the patient (or a caregiver) or a home healthcare nurse. Outcomes measured indicated that self-administration positively impacted patient and family satisfaction and posed no additional safety risks.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into rapid-acting...
Documentation in Long-Term and Home Healthcare Setting
Long-Term Care Facilities

